Pharmacotherapy in Addiction

Medication-assisted treatment supports recovery by reducing withdrawal symptoms and cravings. Different substances require distinct pharmacological interventions. Drugs like naltrexone, buprenorphine, and methadone modulate opioid receptors to reduce relapse risk. Pharmacotherapy is most effective when combined with behavioral therapy. Patient adherence is critical to avoid complications. Research continues to explore novel receptor-targeted therapies.

Therapeutic Medication Pathways:

• Evidence for pharmacological agents
• Patient-specific medication selection
• Novel neuro-targeted therapeutics

    Related Conference of Pharmacotherapy in Addiction

    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    March 09-10, 2026

    7th Annual Congress on Psychiatry

    Singapore City, Singapore
    March 23-24, 2026

    4th World Congress on Psychiatry

    Tokyo, Japan
    April 13-14, 2026

    8th International Congress on Mental Health

    Tokyo, Japan
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France
    June 01-02, 2026

    11th International Conference on Addiction Therapy

    Zurich, Switzerland

    Pharmacotherapy in Addiction Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in